CollPlant Biotechnologies (CLGN) Shares Outstanding (2017 - 2026)

CollPlant Biotechnologies (CLGN) has 10 years of Shares Outstanding (Entity) data on file, last reported at $13.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 20.02% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (up 20.02% YoY) and the FY2025 annual result came in at $12.2 million, up 6.54% from the prior year.
• Shares Outstanding (Entity) climbed to $13.7 million in Q1 2026, from $12.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $13.7 million in Q1 2026 to a low of $10.8 million in Q1 2022.
• A 5-year average of $11.6 million and a median of $11.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 28.16% — and 2025, when it climbed 0.01%.
• Tracing CLGN's Shares Outstanding (Entity) over 5 years: stood at $11.0 million in 2022, then climbed by 3.23% to $11.4 million in 2023, then rose by 0.57% to $11.5 million in 2024, then grew by 6.54% to $12.2 million in 2025, then grew by 12.65% to $13.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $13.7 million (Q1 2026), $12.2 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.